Dana-Farber Cancer Institute

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Dana-Farber Cancer Institute

https://www.dana-farber.org/

LYNKED IN Patient Conference 2024
Multiple Myeloma Patient Symposium
2023-2024 EMBRACE MBC Virtual Forum Series
ASCO® GU 2024
ASCO® 2023
COVID-19
Leukemia
Lymphoma
Myeloma
MDS and MPN
Breast
Lung
Gynecologic
Genitourinary
Gastrointestinal
Colorectal
Basic Science
Supportive and Palliative Care
CNS
Skin
Head and Neck
Business

Small Cell Lung Cancer: A Brief Review of the Treatment Landscape

By Dana-Farber Cancer Institute FEATURING Jacob Sands

612 views

November 8, 2021

Comments 0

Hypothetical Patient Case: Hepatocellular Carcinoma with Progression…

Feat. J. Gutierrez, J. Strauss

Hypothetical Patient Case: Hepatocellular Carcinoma and Consideratio…

Feat. J. Gutierrez, J. Strauss

Lung

Risk of Hepatotoxicity From Sequential IO Followed by KRASG12C Targe…

Dana-Farber Cancer Institute

B. Ricciuti

231 views

Updates in KRAS G12C Mutant NSCLC: Demographics, Clinical Features, …

Dana-Farber Cancer Institute

B. Ricciuti

242 views

ESMO 2023 Insights: "Phase 2 KRYSTAL-7 Trial - Adagrasib+Pembro Comb…

ecancer

P. Janne

100 views

WCLC 2023 Insights: "Association of TTF-1 Expression With Outcomes t…

Insights from 2023 WCLC

A. Di Federico

88 views

WCLC 2023 Insights: "Mechanisms of Resistance to KRAS G12C Inhibitor…

Insights from 2023 WCLC

B. Ricciuti

98 views

WCLC 2023 Insights: "3-Year Outcomes & Correlative Analyses in Patie…

Insights from 2023 WCLC

B. Ricciuti

102 views

Small Cell Lung Cancer: A Brief Review of the Treatment Landscape

Dana-Farber Cancer Institute

J. Sands

612 views